medigraphic.com
Instituto Nacional de Salud Pública

2006, Number S1

<< Back Next >>

salud publica mex 2006; 48 (S1)

Literature review of health care costs of diseases attributable to tobacco consumption in the Americas

Reynales-Shigematsu LM

Language: Spanish
References: 36
Page: 190-200
PDF size: 112.50 Kb.


ABSTRACT

The objective of this study was to compile information from published scientific literature about health care costs attributable to tobacco consumption and evaluate the different methodological strategies used in calculating estimations. Sources included MedLINE, bibliographical references from books published by the World Bank, the World Health Organization, the Panamerican Health Organization, the Interdisciplinary Health Research Group of Canada, as well as technical documenation used by the state of Minnesota, United States of America, in litigation against the tobacco industry. All of the studies published about this issue over the last 25 years or more were included. Information was obtained with respect to the study population, the cost perspective, the type of analysis used for estimating health care costs and methodology for attributing costs to tobacco consumption. In addition, comments with regard to the relevant findings and the limitations of each of the studies were added. Annual health care costs attributable to tobacco use vary between 6 and 14% of personal health expenses. In the period between the first publication and today, progress has been seen in the methodology used for calculating estimations, not only from the epidemiological perspective which improves the accuracy of the attribution of costs to risk factors, but from the economic perspective which broadens the estimation of costs from a social perspective. It is concluded that tobacco consumption leads to high health care costs, involves a cost to employers due to productivity losses and worker disability, and represents a high social cost resulting from the occurrence of premature deaths in the society.


REFERENCES

  1. World Bank. Curbing the epidemic: Governments and economics of tobacco control. Washington, DC: World Bank; 1999.

  2. Departamento de Salud y Servicios Sociales de los Estados Unidos de América. Tabaquismo y Salud en las Américas. Publicación No. (CDC) 92-8420. Atlanta, Georgia: USDHHS, 1992:9-15.

  3. Kumra V, Markoff BA. Who´s smoking now? The epidemiology of tobacco use in the United States and abroad. Clin Chest Med 2000:21;1-9.

  4. Warner K, Hodgson TA, Carroll C. Medical cost of smoking in the United States: Estimates, their validity, and their implications. Tob control 1999; 8:290-300.

  5. Leistikow BN. The human and financial costs of smoking. En: Smoking and pulmonary and cardiovascular diseases. Clin Chest Med 2000;21(1):189-195.

  6. Max W. The financial impact of smoking on health-related cost: A review of the literature. Am J Health Promot 2001;15(5):321-331.

  7. U.S. Department of Health, Education and Welfare. Smoking and Health. Report of the Advisory Committee to the Surgeon General of the Public Health Service. Publication No. (PHS) 1103. Washington, DC: USDHEW, 1964:33-42.

  8. U.S. Department of Health and Human Services. The Health Consequences of Smoking: Cancer. A Report of the Surgeon General. Publication No. (PHS) 82–50179. Washington, DC: USDHHS, 1982:1-11.

  9. U.S. Department of Health and Human Services (USDHHS). The Health Consequences of Smoking: Cardiovascular Disease. A Report of the Surgeon General. Publication No. (PHS) 84–50204. Rockville (MD): USDHHS, 1983:1-11.

  10. Great Britain Scientific Committee on Tobacco and Health Great Britain Department of Health Scientific Committee on Tobacco and Health. Report of the Scientific Committee on Tobacco and Health. London: Pitman Medical Publishing Co., 1988:3-8.

  11. Samet J. Los riesgos del tabaquismo activo y pasivo. Salud Publica Mex 2002;44 (SI):S144-S160.

  12. U S Department of Health and Human Services (USDHHS). The health consequences of smoking: A Report of the Surgeon General. Atlanta (GA): U S Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004.

  13. Lightwood J, Collins D, Lapsley H, Novotny T. Estimating the costs of tobacco use. En: Jha P, Chaloupka F, ed. Tobacco control in developing countries. Oxford: Oxford University Press, 2000: 63-99.

  14. Hendrick JL. The economic cost of cigarette smoking. HSMHA Health Rep 1971;86:179-182.

  15. Kristein MM. Economic issues in prevention. Prev Med 1977;6:252-264.

  16. Luce BR, Schweitzer SO. Smoking and alcohol abuse: A comparison of their economic consequences. N Engl J Med 1978;298:569-571.

  17. Office of Technology Assessment (OTA), U S Congress. Smoking-related deaths and financial costs. Washington, DC: Health Program, OTA; 1985. OTA staff memorandum.

  18. Rice DP, Hodgson TA, Sinsheimer P,Browner W, Kopstein AN. The economic costs of the health effects of smoking, 1984. Milbank Q 1986;64 (4):489-547.

  19. Barlett JC, Miller LS, Rice DP, Max W. Medical expenditures attributable to cigarrette smoking –United States, 1993. MMWR Morb Mortal Wkly Rep 1994;43:469-472.

  20. Miller LS, Zhang X, Rice DP, Max W. State estimates of total medical expenditures attributable to cigarette smoking, 1993. Public Health Rep 1998;113:447-458.

  21. Miller VP, Ernst C, Collin F. Smoking-attributable medical care costs in the USA. Soc Sci Med 1999;48:375-391.

  22. Warner K. The economics of tobacco: Myths and realities. Tob Control 2000;9:78-89.

  23. Zeger SL, Wyant T, Miller LS, Samet J. Statistical testimony on damages in Minnesota v. Tobacco industry. En: Gastwirth J. Statistical in the Courtroom. Nueva York (NY): Springer- Verlag; 2000.

  24. Johnson E, Dominici F, Griswold M, Zeger SL. Disease cases and their medical costs attributable to smoking: An analysis of the national medical expenditures survey. J Econometrics 2003;112:135–151.

  25. Dominici F, Zeger SL. Smooth quantile ratio estimation with regression: Estimating medical expenditures for smoking attributable diseases. Biostatistics 2005;6:505-519.

  26. Arredondo A, Parada I, Carrillo C. Financial consequences of changes in health care demands related to tobacco consumption in Mexico: Information for policy makers. Health Policy 2002;61:43-45.

  27. Reynales-Shigematsu LM, Juárez-Márquez SA, Hernández-Ávila M. Costos de la atención médica de enfermedades atribuibles al consumo de tabaco. En: Primer informe sobre combate al tabaquismo. México ante el Convenio Marco para el Control del Tabaco. México. Cuernavaca: Instituto Nacional de Salud Pública; 2005:77-85.

  28. Reynales-Shigematsu LM, Juárez-Márquez SA, Valdés-Salgado R. Costos de atención médica atribuibles al tabaquismo en el IMSS, Morelos. Salud Publica Mex 2005;47(6):451–457.

  29. Leu Re, Schaub T. Does smoking increase medical care expenditure? Soc Sci Med 1983;17(23):1907–1914.

  30. Oster G, Colditz GA, Kelly NL. The economic cost of smoking and benefits of quitting for individual smokers. Prev Med 1984;13:377-389.

  31. Manning WG, Keeler EB, Newhouse JP, Sloss EM, Waserman J. The taxes of sin. Do smokers and drinkers pay their way? JAMA 1989;261:1604-1609.

  32. Lippiat BC. Measuring medical cost and life expectancy impacts of changes in cigarette sales. Prev Med 1990;19:515-532.

  33. Hodgson T. Cigarette Smoking and lifetime Medical Expenditures. Milbank Q 1992;70(1):81-125.

  34. Viscusi WK. Cigarette taxation and the social consequences of smoking. En Tax policy and the economy: Cambridge: National Bureau of economic research/ MIT Press, 1995.

  35. Sloan F, Ostermann J, Picone G, Conover C, Taylor Jr. D. The price of smoking. Cambridge: The MIT Press; 2004.

  36. Barendregt JJ, Bonneu L, Van Der Mass PJ. The health care costs of smoking. N Engl J Med 1997;337:1052-1057.




2020     |     www.medigraphic.com